Mergers & Acquisitions in the Pharmaceutical Industry
An empirical study of acquirers' ability to create shareholder wealth
(Sprache: Englisch)
Abnormal returns in stock markets are subject to many studies. In particular, the ability to test on specific industries has received much attention. The number of M&As have increased in the last decade, which also includes M&A deals in the pharmaceutical...
Leider schon ausverkauft
versandkostenfrei
Buch
17.90 €
8 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
Produktdetails
Produktinformationen zu „Mergers & Acquisitions in the Pharmaceutical Industry “
Klappentext zu „Mergers & Acquisitions in the Pharmaceutical Industry “
Abnormal returns in stock markets are subject to many studies. In particular, the ability to test on specific industries has received much attention. The number of M&As have increased in the last decade, which also includes M&A deals in the pharmaceutical (pharma) industry, where companies acquire to reach distinctive capabilities to survive in the dynamic and complex business environment. Companies also utilize M&A to increase their ability to create shareholder wealth, though this has shown partially not to be correct. Previous studies conducted, have found rather different results on M&A transactions. This thesis examines the impact on shareholder wealth in pharmaceutical M&As, more precise the study tests the abnormal stock return around the announcement day. The study is conducted with a data sample consisting of 250 deals in the pharma industry between 2000 and 2014.
Bibliographische Angaben
- Autoren: Jimmy Thien Phu Nguyen , Thomas Grauer Nielsen
- 2017, 80 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 3330070439
- ISBN-13: 9783330070431
Sprache:
Englisch
Kommentar zu "Mergers & Acquisitions in the Pharmaceutical Industry"
0 Gebrauchte Artikel zu „Mergers & Acquisitions in the Pharmaceutical Industry“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Mergers & Acquisitions in the Pharmaceutical Industry".
Kommentar verfassen